CliffBio
small molecule

ARGATROBAN IN SODIUM CHLORIDE

ARGATROBAN

Loss of exclusivitySeptember 2027latest FDA-listed patent expiry
CompanyCipla →View the full company profile on CliffBio

Drug detail

Brand nameARGATROBAN IN SODIUM CHLORIDE
Active ingredientARGATROBAN
Strength50MG/50ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formINJECTABLE
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJune 2011
Marketing statusDISCN

Listed patents

PatentExpiresType
7687516September 2027product
7589106September 2027product

More from Cipla

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ARGATROBAN IN SODIUM CHLORIDE patent cliff — loss of exclusivity September 2027 | CliffBio